StocksMediumUpdated•Originally published 13 November 2026•Updated 13 November 2026•
1 min read
SBC Medical Revenue Surges 35% in Q3 2026 Financial Results
Key Facts
1SBC Medical revenue increased 35% year-over-year in the third quarter of 2026.
2Net income attributable to the company grew 22%, while Adjusted EBITDA surged 66%.
3The company achieved a net income margin of 27% and an Adjusted EBITDA margin of 47%.
SBC Medical revenue increased 35% year-over-year in the third quarter of 2026. Business Wire reported that net income attributable to the company grew 22%, while Adjusted EBITDA surged 66% for the period ending September 30, 2026.
The company achieved a net income margin of 27% and an Adjusted EBITDA margin of 47%, indicating strong operational performance. SBC closed at $5.34 on November 12, 2026, after reaching a session high of $5.39 and a low of $5.2.
Latest Updates · 1
- Notable·
Update: SBC Medical earnings beat analyst estimates by $0.03 per share during the third quarter of 2026. Reported revenue also exceeded initial market expectations for the period ending September 30, 2026.